Recent data from the U.S estimated that over half (57%) of transgender women (TW), aged 50+, are living with HIV. Findings lacked analysis by age, gender, and race/ethnicity, but found 62% HIV prevalence among Black trans women, suggesting potential HIV disparities for older TW of color. This study focused on HIV outcomes and health services access for TW aged 50 and older, making important contributions to the context of care for this population sub-group, who shoulder disproportionately high HIV prevalence. Findings highlight the critical role of support services in HIV care engagement and the potential for expanded access and intergenerational peer support programs to ameliorate HIV-related disparities based on age and race.

In this session, participants will learn about the core elements of a community -based syndemic approach to HIV care engagement to enhance capacity to support PLWH throughout the HIV care continuum. This workshop will demonstrate how community health workers improve involvement in comprehensive prevention services.

This systematic review explores the role of CAB + RPV-LA injectables in antiretroviral therapy (ART), with a focus on patient-reported outcomes from five key clinical trials.

This session presents data from the National Substance Use and Mental Health Services Survey (2023) conducted by the Substance Abuse and Mental Health Services Administration to present the current state of availability of testing and treatment services for HIV, HCV, and STIs.

Having previously reported on clinical outcomes of Adolescents and Young Adults with HIV (AYAHIV) in the Accessing Care Early (ACE) young adult transition program, we present an update, detailing the design and implementation of this multi-dimensional program, the innovations in biomedical and care delivery interventions, as well as programmatic challenges and opportunities as we evolve into a mature transition program. This workshop will use didactics and interactive presentation, case-study, transparent panel discussion and Q&A as participants engage with the ACE program’s multidisciplinary team, including an YAHIV who “came of age” in the program.

As people living with HIV (PLWH) age, cognitive decline presents a growing yet underaddressed challenge. This presentation highlights an innovative collaboration between The Grand Rapids Red Project (TGRRP) and the Alzheimer’s Association Michigan Chapter (AAMC) to implement routine cognitive screenings within TGRRP’s HIV care programs. The initiative targets PLWH aged 44+ and those exhibiting overt cognitive impairment, aiming to bridge gaps in care complexity for aging populations.

In this presentation, AAMC will review national trends in HIV-associated neurocognitive disorders (HAND) and statewide efforts to develop programming for aging PLWH through partnerships with community-based organizations (CBOs). With AAMC’s support, TGRRP designed an HIV and aging pilot program featuring tailored screening tools, staff training, and referral pathways—offering replicable strategies for similar programs.

With advancements in HIV treatment, individuals living with HIV are now living longer, By 2030, 70% of people living with HIV (PLWH) will be ages 50 and older. But, as PLWH age they face unique challenges, particularly with cognitive health. One major concern is HIV-Associated Neurocognitive Disorder (HAND), a form of cognitive decline more common among PLWH. This presentation will provide a brief overview of HIV care; the signs and risk factors for HAND; similarities and differences between HAND and Alzheimer's disease; and why accurately diagnosing cognitive change in PLWH is so important.

This presentation will explore critical considerations in the management of HIV in the context of pregnancy, focusing on evidence-based practices and clinical guidelines. Divided into three clinically relevant scenarios, the session will address: (1) treatment and monitoring of HIV in pregnant individuals, (2) postnatal management of infants with in utero exposure to HIV, and (3) considerations for HIV-positive parents who plan to breastfeed. Each topic will be anchored by a clinical case, offering participants an opportunity to apply current guidelines. Emphasis will be placed on reducing risk of perinatal HIV transmission, optimizing maternal and infant outcomes, and navigating ethical and cultural factors in decision making. Attendees will leave with practical clinical pearls and an updated understanding of best practices in HIV care during pregnancy and the postpartum period.